Reproductive Genetic Innovations to Discuss Novelties in Preimplantation Genetic Diagnosis in Mexico
Reproductive Genetic Innovations (RGI) will be attending and presenting at the 54th Mexican Congress of Reproductive Medicine hosted by the Associacion Mexicana de Medicina de la Reproduccion, A.C. (AMMR). This is the first year RGI has attended and presented at this conference. Booth G-H (July 17th to the 20th)President and Lab Director, Dr. Svetlana Rechitsky, will be giving a lecture on Wednesday afternoon (July 19th) titled, "Novelties in Preimplantation Genetic Diagnosis of Aneuploidies (PGD-A) and single gene disorders (PGD)." This lecture promises to inspire physicians and scientists new to the PGD field while offering exciting new information to those who have been in the field for decades.
The Congress meets annually, and while RGI has been very active in the global arena of reproductive medicine, this is not a conference they have attended previously. Of this, Shashwat Baxi, MBA, Director of Business Operations, says, "The year is right for us to attend this congress for the first time. We have been constantly working to grow our international presence in the PGD marketplace and this event will be an excellent opportunity to focus on Mexico and Central America. With Day 5/Frozen transfers becoming more and more predominant in this community, no patient or clinic is too far away for us to be able to service."
Reproductive Genetic Innovations is the original innovator of Preimplantation Genetic Diagnosis for single gene disorders almost three decades ago. Since then, the Company has dedicated itself to new innovations in Reproductive Medicine while honing the PGD testing process for monogenic disorders, chromosomal abnormalities, and HLA matching. Today, the Company has a global reach from its headquarters just North of Chicago in Northbrook, Il.
PO Box 871346
Canton, MI
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Reproductive Genetic Innovations to Discuss Novelties in Preimplantation Genetic Diagnosis in Mexico here
News-ID: 627887 • Views: …
More Releases for PGD
Preimplantation Genetics Diagnosis (PGD) Market Key Findings, Growth Strategy, T …
Preimplantation Genetics Diagnosis (PGD) Market - Overview
The size of the preimplantation genetics diagnosis (PGD) market has been estimated to grow at a significant speed in the forthcoming years. This rapid growth in the market is on the basis of the high accuracy of the PGD in order to detect genetic disorders. In addition to this, increasing investment to detect genetic disorders along with chromosomal abnormalities around the world is also…
Preimplantation Genetics Diagnosis (PGD) Market Current Scenario Trends, Compreh …
Preimplantation Genetics Diagnosis (PGD) Market - Overview
The size of the preimplantation genetics diagnosis (PGD) market has been estimated to grow at a significant speed in the forthcoming years. This rapid growth in the market is on the basis of the high accuracy of the PGD in order to detect genetic disorders. In addition to this, increasing investment to detect genetic disorders along with chromosomal abnormalities around the world is also…
Preimplantation Genetics Diagnosis (PGD) Market: Increasing Demand for Efficient …
The world PGD market is expected to witness notable growth in the coming years owning to the rising prevalence of genetic, hereditary and chromosomal diseases. Moreover, PGD have high chances of conceiving healthy embryos. However, the high costs incurred in the PGD technologies hamper the growth of the market. Moreover, stringent government regulations and ethical concerns also obstruct the growth of the market. In coming years, there would be increase…
Preimplantation Genetic Diagnosis (PGD) Market – Industry Growth Analysis & Fo …
CRIFAX added a report on ‘Preimplantation Genetic Diagnosis (PGD) Market Analysis Report, Global Outlook (U.S., Canada, UK, Germany, France, Italy, Spain, Netherlands, Russia, China, India, Japan, Australia, South Korea, Malaysia, Brazil, Mexico, Argentina, GCC, South Africa), Growth Potential, Competitive Market Share & Forecast, 2019 – 2028’to its database of market research collaterals consisting of overall market scenario with prevalent and future growth prospects, among other growth strategies used by key…
Global Preimplantation Genetic Diagnosis (PGD) Market is Anticipated to Reach US …
A new Transparency Market Research report states that the global preimplantation genetic diagnosis (PGD) market stood at US$77.2 mn in 2013 and is anticipated to reach US$118 mn by 2020, by expanding at a CAGR of 6.28% from 2014 to 2020. The title of the report is “Preimplantation Genetic Diagnosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020.”
Preimplantation genetic diagnosis (PGD) is the genetic…
Global Preimplantation Genetic Diagnosis Market (PGD) to Reach $121.50 Million b …
Market Research Reports Search Engine (MRRSE) has been serving as an active source to cater intelligent research report to enlighten both readers and investors. This research study titled “Preimplantation Genetic Diagnosis Market “
Get Free Sample Report @ https://www.mrrse.com/sample/1351
Since the last two decades, preimplantation genetic diagnosis (PGD) has been used to detect chromosomal aneuploidy in low prognosis patients who undergo in-vitro fertilization (IVF). PGD is now being used to detect a broader…